Precision Optics (NASDAQ:POCI – Get Rating) and Viveve Medical (NASDAQ:VIVE – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability.
Earnings & Valuation
This table compares Precision Optics and Viveve Medical's top-line revenue, earnings per share and valuation.
Get Precision Optics alerts:| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Precision Optics | $15.68 million | 2.51 | -$930,000.00 | $0.14 | 49.93 |
| Viveve Medical | $6.43 million | 0.16 | -$22.03 million | ($2.65) | -0.04 |
Precision Optics has higher revenue and earnings than Viveve Medical. Viveve Medical is trading at a lower price-to-earnings ratio than Precision Optics, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Precision Optics and Viveve Medical's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Precision Optics | 3.50% | 1.27% | 0.67% |
| Viveve Medical | -355.33% | -306.23% | -130.69% |
Volatility & Risk
Precision Optics has a beta of 0.43, indicating that its share price is 57% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings for Precision Optics and Viveve Medical, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Precision Optics | 0 | 0 | 0 | 0 | N/A |
| Viveve Medical | 0 | 1 | 0 | 0 | 2.00 |
Viveve Medical has a consensus price target of $5.25, indicating a potential upside of 5,257.14%. Given Viveve Medical's higher probable upside, analysts clearly believe Viveve Medical is more favorable than Precision Optics.
Institutional and Insider Ownership
25.4% of Precision Optics shares are owned by institutional investors. Comparatively, 5.1% of Viveve Medical shares are owned by institutional investors. 22.7% of Precision Optics shares are owned by insiders. Comparatively, 5.7% of Viveve Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
Precision Optics beats Viveve Medical on 11 of the 12 factors compared between the two stocks.
About Precision Optics
(Get Rating)
Precision Optics Corp., engages in the design, development, manufacture, and selling of optical instruments. Its products include microprecision lenses and micro medical camera, 3D endoscope, and robotic surgery systems. The company was founded by Richard E. Forkey in December 1982 and is headquartered in Gardner, MA.
About Viveve Medical
(Get Rating)
Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. It offers cryogen-cooled monopolar radio frequency technology, which delivered through a radiofrequency generator, hand piece and treatment tip. The Viveve system is a non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company was founded on March 3, 1987 and is headquartered Englewood, CO.
Receive News & Ratings for Precision Optics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Optics and related companies with MarketBeat.com's FREE daily email newsletter.